LCTX

SEC source: 0000919574-24-003898 · ownership.xml · derivative · entry 1

BRADSHER NEAL C · CIK 0001278388 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 75,000

Underlying: COMMON SHARES · 75,000 shares

Expires 2034-07-01

F2 · price: These options were granted to the Reporting Person by the Issuer on July 1, 2024 as director compensation pursuant to the Issuer's 2021 Equity Incentive Plan, as amended.

F1 · derivative.exercise_date: These options will vest and become exercisable on July 1, 2025, provided, that Neal C. Bradsher (the "Reporting Person") remains a member of the board of directors of Lineage Cell Therapeutics, Inc. (the "Issuer") on that date.

SEC source: 0000950170-24-064896 · ownership.xml · nonDerivative · entry 1

Culley Brian M · CIK 0001310683 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 154,842

F1 · price: The price reported is a weighted average. The shares were purchased in multiple transactions at prices ranging from not less than $1.05 to not more than $1.06. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within such range.

SEC source: 0001493152-24-009382 · ownership.xml · derivative · entry 1

Culley Brian M · CIK 0001310683 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,900,000

Underlying: Common Shares · 1,900,000 shares

Expires 2034-03-07

F1 · derivative.exercise_date: One quarter of the options shall vest on March 7, 2025, and the balance shall vest in 36 monthly installments thereafter upon the completion of each month of continuous employment.

SEC source: 0001493152-24-009384 · ownership.xml · derivative · entry 1

Samuel George A. III · CIK 0001878732 · General Counsel/Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 650,000

Underlying: Common Shares · 650,000 shares

Expires 2034-03-07

F1 · derivative.exercise_date: One quarter of the options shall vest on March 7, 2025, and the balance shall vest in 36 monthly installments thereafter upon the completion of each month of continuous employment.

SEC source: 0001493152-24-009379 · ownership.xml · derivative · entry 1

Howe Jill Ann · CIK 0001892397 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 650,000

Underlying: Common Shares · 650,000 shares

Expires 2034-03-07

F1 · derivative.exercise_date: One quarter of the options shall vest on March 7, 2025, and the balance shall vest in 36 monthly installments thereafter upon the completion of each month of continuous employment.

SEC source: 0001493152-24-005944 · ownership.xml · derivative · entry 3

Samuel George A. III · CIK 0001878732 · General Counsel/Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,151

Underlying: Common Shares · 6,076 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The Reporting Person was granted 24,303 RSUs on February 11, 2022, that vested or will vest (subject to continuous service) with respect to approximately 25% of the shares subject to the award on each of February 11, 2023, 2024, 2025 and 2026.

F4 · derivative.expiration_date: The Reporting Person was granted 24,303 RSUs on February 11, 2022, that vested or will vest (subject to continuous service) with respect to approximately 25% of the shares subject to the award on each of February 11, 2023, 2024, 2025 and 2026.

SEC source: 0001493152-24-005944 · ownership.xml · nonDerivative · entry 2

Samuel George A. III · CIK 0001878732 · General Counsel/Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,184

F3 · shares: Shares withheld by the issuer to satisfy statutory tax withholding requirements on the vesting of 6,076 RSUs in a transaction exempt under Rule 16(b)-3. No shares were sold in connection with this transaction.

F2 · balance_after: Does not include RSUs that may be settled in shares of the issuer's common stock that have not vested as of the date hereof or shares that may be acquired upon the exercise of certain stock options.

SEC source: 0001493152-24-005944 · ownership.xml · nonDerivative · entry 1

Samuel George A. III · CIK 0001878732 · General Counsel/Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,674

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Shares earned by the Reporting Person as a result of the vesting of a portion of Restricted Stock Units ("RSUs") granted to the Reporting Person on February 11, 2022. RSUs convert into common shares on a one-for-one basis.

F1 · price: Shares earned by the Reporting Person as a result of the vesting of a portion of Restricted Stock Units ("RSUs") granted to the Reporting Person on February 11, 2022. RSUs convert into common shares on a one-for-one basis.

F2 · balance_after: Does not include RSUs that may be settled in shares of the issuer's common stock that have not vested as of the date hereof or shares that may be acquired upon the exercise of certain stock options.

SEC source: 0001493152-24-005942 · ownership.xml · derivative · entry 3

Culley Brian M · CIK 0001310683 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 62,499

Underlying: Common Shares · 31,249 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The Reporting Person was granted 124,997 RSUs on February 11, 2022, that vested or will vest (subject to continuous service) with respect to approximately 25% of the shares subject to the award on each of February 11, 2023, 2024, 2025 and 2026.

F4 · derivative.expiration_date: The Reporting Person was granted 124,997 RSUs on February 11, 2022, that vested or will vest (subject to continuous service) with respect to approximately 25% of the shares subject to the award on each of February 11, 2023, 2024, 2025 and 2026.

SEC source: 0001493152-24-005942 · ownership.xml · nonDerivative · entry 2

Culley Brian M · CIK 0001310683 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 144,842

F3 · shares: Shares withheld by the issuer to satisfy statutory tax withholding requirements on the vesting of 31,249 RSUs in a transaction exempt under Rule 16(b)-3. No shares were sold in connection with this transaction.

F2 · balance_after: Does not include RSUs that may be settled in shares of the issuer's common stock that have not vested as of the date hereof or shares that may be acquired upon the exercise of certain stock options.

SEC source: 0001493152-24-005942 · ownership.xml · nonDerivative · entry 1

Culley Brian M · CIK 0001310683 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 157,648

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Shares earned by the Reporting Person as a result of the vesting of a portion of Restricted Stock Units ("RSUs") granted to the Reporting Person on February 11, 2022. RSUs convert into common shares on a one-for-one basis.

F1 · price: Shares earned by the Reporting Person as a result of the vesting of a portion of Restricted Stock Units ("RSUs") granted to the Reporting Person on February 11, 2022. RSUs convert into common shares on a one-for-one basis.

F2 · balance_after: Does not include RSUs that may be settled in shares of the issuer's common stock that have not vested as of the date hereof or shares that may be acquired upon the exercise of certain stock options.

SEC source: 0001493152-24-005510 · ownership.xml · nonDerivative · entry 1

BAILEY DON M · CIK 0001223697 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By The Bailey Family Trust

Disclosed balance after: 158,801

F1 · balance_after: Does not include common shares that may be acquired upon the exercise of stock options outstanding as of the date of this report.

SEC source: 0000919574-24-000757 · ownership.xml · nonDerivative · entry 2

BROADWOOD PARTNERS, L.P. · CIK 0001278386 · Director · 10% owner

BROADWOOD CAPITAL INC · CIK 0001278387 · 10% owner

BRADSHER NEAL C · CIK 0001278388 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 41,666,255

F1 · ownership.nature: The reported securities are directly owned by Broadwood Partners, L.P. ("Broadwood Partners") and may be deemed beneficially owned by Broadwood Capital, Inc. as General Partner of Broadwood Partners and Neal C. Bradsher as President of Broadwood Capital, Inc. Each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

SEC source: 0000919574-24-000757 · ownership.xml · nonDerivative · entry 1

BROADWOOD PARTNERS, L.P. · CIK 0001278386 · Director · 10% owner

BROADWOOD CAPITAL INC · CIK 0001278387 · 10% owner

BRADSHER NEAL C · CIK 0001278388 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 41,666,255

F2 · price: On February 6, 2024, Broadwood Partners entered into a Stock Purchase Agreement with Lineage Cell Therapeutics, Inc. (the "Issuer") pursuant to which Broadwood Partners agreed to acquire 6,730,770 shares of the Issuer's Common Stock, no par value (the "Common Shares"), from the Issuer in its registered direct offering for a total purchase price of $7,000,000.80, or $1.04 per Common Share.

F1 · ownership.direct: The reported securities are directly owned by Broadwood Partners, L.P. ("Broadwood Partners") and may be deemed beneficially owned by Broadwood Capital, Inc. as General Partner of Broadwood Partners and Neal C. Bradsher as President of Broadwood Capital, Inc. Each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

SEC source: 0001493152-24-000154 · ownership.xml · nonDerivative · entry 1

Jayasuriya Anula · CIK 0001822933 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,000

F1 · price: The price reported is a weighted average. The shares were purchased in multiple transactions at prices ranging from not less than $1.08 to not more than $1.09. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within such range.

F2 · balance_after: Does not include common shares that may be acquired upon the exercise of stock options outstanding as of the date of this report.

SEC source: 0001493152-23-023347 · ownership.xml · derivative · entry 1

Mulroy Michael H. · CIK 0001509725 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Shares · 50,000 shares

Expires 2033-07-01

F1 · derivative.exercise_date: Will vest and become exercisable on July 1, 2024, subject to the reporting person's continuous service with the issuer.

SEC source: 0001493152-23-023344 · ownership.xml · derivative · entry 1

BAILEY DON M · CIK 0001223697 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Shares · 50,000 shares

Expires 2033-07-01

F1 · derivative.exercise_date: Will vest and become exercisable on July 1, 2024, subject to the reporting person's continuous service with the issuer.

SEC source: 0001493152-23-023342 · ownership.xml · derivative · entry 1

Amin Dipti · CIK 0001856708 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Shares · 50,000 shares

Expires 2033-07-01

F1 · derivative.exercise_date: Will vest and become exercisable on July 1, 2024, subject to the reporting person's continuous service with the issuer.

SEC source: 0001493152-23-023348 · ownership.xml · derivative · entry 1

Russell Angus C. · CIK 0001534002 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Shares · 50,000 shares

Expires 2033-07-01

F1 · derivative.exercise_date: Will vest and become exercisable on July 1, 2024, subject to the reporting person's continuous service with the issuer.

SEC source: 0001493152-23-023343 · ownership.xml · derivative · entry 1

ANDREWS DEBORAH J · CIK 0001325697 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Shares · 50,000 shares

Expires 2033-07-01

F1 · derivative.exercise_date: Will vest and become exercisable on July 1, 2024, subject to the reporting person's continuous service with the issuer.

SEC source: 0001493152-23-023346 · ownership.xml · derivative · entry 1

KINGSLEY ALFRED D · CIK 0001229339 · Director · Chairman

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Shares · 50,000 shares

Expires 2033-07-01

F1 · derivative.exercise_date: Will vest and become exercisable on July 1, 2024, subject to the reporting person's continuous service with the issuer.

SEC source: 0001493152-23-023345 · ownership.xml · derivative · entry 1

Jayasuriya Anula · CIK 0001822933 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Shares · 50,000 shares

Expires 2033-07-01

F1 · derivative.exercise_date: Will vest and become exercisable on July 1, 2024, subject to the reporting person's continuous service with the issuer.

SEC source: 0000919574-23-003906 · ownership.xml · derivative · entry 1

BRADSHER NEAL C · CIK 0001278388 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,000

Underlying: COMMON SHARES · 50,000 shares

Expires 2033-07-01

F2 · price: These options were granted to the Reporting Person by the Issuer on July 1, 2023 as director compensation pursuant to the Issuer's 2021 Equity Incentive Plan, as amended.

F1 · derivative.exercise_date: These options will vest and become exercisable on July 1, 2024, provided, that Neal C. Bradsher (the "Reporting Person") remains a member of the board of directors of Lineage Cell Therapeutics, Inc. (the "Issuer") on that date.

SEC source: 0001493152-23-007310 · ownership.xml · derivative · entry 1

Hogge Gary S. · CIK 0001771711 · SVP,Clinical & Medical Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 400,000

Underlying: Common Shares · 400,000 shares

Expires 2033-03-09

F1 · derivative.exercise_date: One quarter of the options shall vest on March 9, 2024, and the balance shall vest in 36 monthly installments thereafter upon the completion of each month of continuous employment.

SEC source: 0001493152-23-007308 · ownership.xml · derivative · entry 1

Samuel George A. III · CIK 0001878732 · General Counsel/Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 650,000

Underlying: Common Shares · 650,000 shares

Expires 2033-03-09

F1 · derivative.exercise_date: One quarter of the options shall vest on March 9, 2024, and the balance shall vest in 36 monthly installments thereafter upon the completion of each month of continuous employment.

SEC source: 0001493152-23-007306 · ownership.xml · derivative · entry 1

Culley Brian M · CIK 0001310683 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,900,000

Underlying: Common Shares · 1,900,000 shares

Expires 2033-03-09

F1 · derivative.exercise_date: One quarter of the options shall vest on March 9, 2024, and the balance shall vest in 36 monthly installments thereafter upon the completion of each month of continuous employment.

SEC source: 0001493152-23-007304 · ownership.xml · derivative · entry 1

Howe Jill Ann · CIK 0001892397 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 150,000

Underlying: Common Shares · 150,000 shares

Expires 2033-03-09

F1 · derivative.exercise_date: One quarter of the options shall vest on March 9, 2024, and the balance shall vest in 36 monthly installments thereafter upon the completion of each month of continuous employment.

SEC source: 0001493152-23-004898 · ownership.xml · derivative · entry 3

Culley Brian M · CIK 0001310683 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 93,748

Underlying: Common Shares · 31,249 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The Reporting Person was granted RSUs on February 11, 2022 that vested with respect to 25% of the shares subject to the award on February 11, 2023, and the balance will vest in 3 equal annual installments on each anniversary date thereafter.

F4 · derivative.expiration_date: The Reporting Person was granted RSUs on February 11, 2022 that vested with respect to 25% of the shares subject to the award on February 11, 2023, and the balance will vest in 3 equal annual installments on each anniversary date thereafter.

SEC source: 0001493152-23-004898 · ownership.xml · nonDerivative · entry 2

Culley Brian M · CIK 0001310683 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 126,399

F3 · shares: Shares withheld by the issuer to satisfy statutory tax withholding requirements on the vesting of 31,249 RSUs in a transaction exempt under Rule 16(b)-3. No shares were sold in connection with this transaction.

F2 · balance_after: Does not include RSUs that may be settled in shares of the issuer's common stock that have not vested as of the date of this Report or shares that may be acquired upon the exercise of certain stock options.

SEC source: 0001493152-23-004898 · ownership.xml · nonDerivative · entry 1

Culley Brian M · CIK 0001310683 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 139,143

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Shares earned by the Reporting Person as a result of the vesting of a portion of Restricted Stock Units ("RSUs") granted to the Reporting Person on February 11, 2022. RSUs convert into common shares on a one-for-one basis.

F1 · price: Shares earned by the Reporting Person as a result of the vesting of a portion of Restricted Stock Units ("RSUs") granted to the Reporting Person on February 11, 2022. RSUs convert into common shares on a one-for-one basis.

F2 · balance_after: Does not include RSUs that may be settled in shares of the issuer's common stock that have not vested as of the date of this Report or shares that may be acquired upon the exercise of certain stock options.

SEC source: 0001493152-23-004895 · ownership.xml · derivative · entry 3

Hogge Gary S. · CIK 0001771711 · SVP,Clinical & Medical Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,061

Underlying: Common Shares · 13,020 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The Reporting Person was granted RSUs on February 11, 2022 that vested with respect to 25% of the shares subject to the award on February 11, 2023, and the balance will vest in 3 equal annual installments on each anniversary date thereafter.

F4 · derivative.expiration_date: The Reporting Person was granted RSUs on February 11, 2022 that vested with respect to 25% of the shares subject to the award on February 11, 2023, and the balance will vest in 3 equal annual installments on each anniversary date thereafter.

SEC source: 0001493152-23-004895 · ownership.xml · nonDerivative · entry 2

Hogge Gary S. · CIK 0001771711 · SVP,Clinical & Medical Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,710

F3 · shares: Shares withheld by the issuer to satisfy statutory tax withholding requirements on the vesting of 13,020 RSUs in a transaction exempt under Rule 16(b)-3. No shares were sold in connection with this transaction.

F2 · balance_after: Does not include RSUs that may be settled in shares of the issuer's common stock that have not vested as of the date of this Report or shares that may be acquired upon the exercise of certain stock options.

SEC source: 0001493152-23-004895 · ownership.xml · nonDerivative · entry 1

Hogge Gary S. · CIK 0001771711 · SVP,Clinical & Medical Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,020

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Shares earned by the Reporting Person as a result of the vesting of a portion of Restricted Stock Units ("RSUs") granted to the Reporting Person on February 11, 2022. RSUs convert into common shares on a one-for-one basis.

F1 · price: Shares earned by the Reporting Person as a result of the vesting of a portion of Restricted Stock Units ("RSUs") granted to the Reporting Person on February 11, 2022. RSUs convert into common shares on a one-for-one basis.

F2 · balance_after: Does not include RSUs that may be settled in shares of the issuer's common stock that have not vested as of the date of this Report or shares that may be acquired upon the exercise of certain stock options.

SEC source: 0001493152-23-004899 · ownership.xml · derivative · entry 3

Samuel George A. III · CIK 0001878732 · General Counsel/Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,227

Underlying: Common Shares · 6,076 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The Reporting Person was granted RSUs on February 11, 2022 that vested with respect to 25% of the shares subject to the award on February 11, 2023, and the balance will vest in 3 equal annual installments on each anniversary date thereafter.

F4 · derivative.expiration_date: The Reporting Person was granted RSUs on February 11, 2022 that vested with respect to 25% of the shares subject to the award on February 11, 2023, and the balance will vest in 3 equal annual installments on each anniversary date thereafter.

SEC source: 0001493152-23-004899 · ownership.xml · nonDerivative · entry 2

Samuel George A. III · CIK 0001878732 · General Counsel/Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,598

F3 · shares: Shares withheld by the issuer to satisfy statutory tax withholding requirements on the vesting of 6,076 RSUs in a transaction exempt under Rule 16(b)-3. No shares were sold in connection with this transaction.

F2 · balance_after: Does not include RSUs that may be settled in shares of the issuer's common stock that have not vested as of the date of this Report or shares that may be acquired upon the exercise of certain stock options.

SEC source: 0001493152-23-004899 · ownership.xml · nonDerivative · entry 1

Samuel George A. III · CIK 0001878732 · General Counsel/Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,076

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Shares earned by the Reporting Person as a result of the vesting of a portion of Restricted Stock Units ("RSUs") granted to the Reporting Person on February 11, 2022. RSUs convert into common shares on a one-for-one basis.

F1 · price: Shares earned by the Reporting Person as a result of the vesting of a portion of Restricted Stock Units ("RSUs") granted to the Reporting Person on February 11, 2022. RSUs convert into common shares on a one-for-one basis.

F2 · balance_after: Does not include RSUs that may be settled in shares of the issuer's common stock that have not vested as of the date of this Report or shares that may be acquired upon the exercise of certain stock options.

SEC source: 0001493152-23-004902 · ownership.xml · nonDerivative · entry 1

KINGSLEY ALFRED D · CIK 0001229339 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,430,545

F1 · price: Represents a gift of 25,000 common shares.

SEC source: 0001493152-22-032631 · ownership.xml · derivative · entry 1

Howe Jill Ann · CIK 0001892397 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,000,000

Underlying: Common Shares · 1,000,000 shares

Expires 2032-11-14

F1 · derivative.exercise_date: This option will vest as to one quarter of the shares subject to the option on November 14, 2023, and the balance will vest in 36 successive substantially equal installments thereafter, subject to the reporting person's continuous employment.

SEC source: 0001493152-22-018685 · ownership.xml · derivative · entry 1

Russell Angus C. · CIK 0001534002 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Shares · 50,000 shares

Expires 2032-07-01

F1 · derivative.exercise_date: Will vest and become exercisable on July 1, 2023, subject to the reporting person's continuous service with the issuer.

SEC source: 0001493152-22-018684 · ownership.xml · derivative · entry 1

ANDREWS DEBORAH J · CIK 0001325697 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Shares · 50,000 shares

Expires 2032-07-01

F1 · derivative.exercise_date: Will vest and become exercisable on July 1, 2023, subject to the reporting person's continuous service with the issuer.

SEC source: 0001493152-22-018680 · ownership.xml · derivative · entry 1

BAILEY DON M · CIK 0001223697 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Shares · 50,000 shares

Expires 2032-07-01

F1 · derivative.exercise_date: Will vest and become exercisable on July 1, 2023, subject to the reporting person's continuous service with the issuer.

SEC source: 0001493152-22-018683 · ownership.xml · derivative · entry 1

Jayasuriya Anula · CIK 0001822933 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Shares · 50,000 shares

Expires 2032-07-01

F1 · derivative.exercise_date: Will vest and become exercisable on July 1, 2023, subject to the reporting person's continuous service with the issuer.

SEC source: 0001493152-22-018682 · ownership.xml · derivative · entry 1

Mulroy Michael H. · CIK 0001509725 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Shares · 50,000 shares

Expires 2032-07-01

F1 · derivative.exercise_date: Will vest and become exercisable on July 1, 2023, subject to the reporting person's continuous service with the issuer.

SEC source: 0001493152-22-018681 · ownership.xml · derivative · entry 1

KINGSLEY ALFRED D · CIK 0001229339 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Shares · 50,000 shares

Expires 2032-07-01

F1 · derivative.exercise_date: Will vest and become exercisable on July 1, 2023, subject to the reporting person's continuous service with the issuer.

SEC source: 0000919574-22-004056 · ownership.xml · derivative · entry 1

BRADSHER NEAL C · CIK 0001278388 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: COMMON SHARES · 50,000 shares

Expires 2032-07-01

F2 · price: These options were granted to the Reporting Person by the Issuer on July 1, 2022 as director compensation pursuant to the Issuer's 2021 Equity Incentive Plan, as amended.

F1 · derivative.exercise_date: These options will vest and become exercisable on July 1, 2023, provided, that Neal C. Bradsher (the "Reporting Person") remains a member of the board of directors of Lineage Cell Therapeutics, Inc. (the "Issuer") on that date.

SEC source: 0001493152-22-018687 · ownership.xml · derivative · entry 1

Amin Dipti · CIK 0001856708 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Shares · 50,000 shares

Expires 2032-07-01

F1 · derivative.exercise_date: Will vest and become exercisable on July 1, 2023, subject to the reporting person's continuous service with the issuer.

SEC source: 0001493152-22-018271 · ownership.xml · derivative · entry 3

Culley Brian M · CIK 0001310683 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Shares · 15,450 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The reporting person was granted RSUs on September 17, 2018, that vested with respect to 25% of the shares subject to the award on September 17, 2019, and the balance vest in 12 equal quarterly installments at the end of each quarter thereafter.

F4 · derivative.expiration_date: The reporting person was granted RSUs on September 17, 2018, that vested with respect to 25% of the shares subject to the award on September 17, 2019, and the balance vest in 12 equal quarterly installments at the end of each quarter thereafter.

SEC source: 0001493152-22-018271 · ownership.xml · nonDerivative · entry 2

Culley Brian M · CIK 0001310683 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 107,894

F3 · shares: Shares withheld by the issuer to satisfy statutory tax withholding requirements on the vesting of 15,450 RSUs in a transaction exempt under Rule 16(b)-3. No shares were sold in connection with this transaction.

F2 · balance_after: Does not include RSUs that may be settled in shares of the issuer's common stock that have not vested as of the date of this report or shares that may be acquired upon the exercise of stock options outstanding as of the date of this report.

SEC source: 0001493152-22-018271 · ownership.xml · nonDerivative · entry 1

Culley Brian M · CIK 0001310683 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 113,237

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Shares earned by the reporting person as a result of the vesting of a portion of restricted stock units ("RSUs") granted to the reporting person on September 17, 2018. RSUs convert into common shares on a one-for-one basis.

F1 · price: Shares earned by the reporting person as a result of the vesting of a portion of restricted stock units ("RSUs") granted to the reporting person on September 17, 2018. RSUs convert into common shares on a one-for-one basis.

F2 · balance_after: Does not include RSUs that may be settled in shares of the issuer's common stock that have not vested as of the date of this report or shares that may be acquired upon the exercise of stock options outstanding as of the date of this report.

SEC source: 0001493152-22-009000 · ownership.xml · derivative · entry 4

Culley Brian M · CIK 0001310683 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,450

Underlying: Common Shares · 15,450 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: The reporting person was granted RSUs on September 17, 2018, that vested with respect to 25% of the shares subject to the award on September 17, 2019, and the balance vest in 12 equal quarterly installments at the end of each quarter thereafter.

F5 · derivative.expiration_date: The reporting person was granted RSUs on September 17, 2018, that vested with respect to 25% of the shares subject to the award on September 17, 2019, and the balance vest in 12 equal quarterly installments at the end of each quarter thereafter.